PUMA BIOTECHNOLOGY, INC.
Cash Flow Statement
| Line Item | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $16.5M | $-15.0M | $-31.5M | $3.4M | $-16.9M | $-11.2M | $-16.9M | $-37.4M |
| Depreciation & Amortization | $3.0M | — | — | — | $1.9M | — | — | — |
| Depreciation | $200.0K | — | $200.0K | $300.0K | $200.0K | — | $200.0K | — |
| Amortization | $2.0M | — | $2.0M | $1.3M | $1.0M | — | $1.0M | $1.0M |
| Stock-Based Compensation | $5.9M | — | — | — | $8.9M | — | — | — |
| Net Cash from Operating Activities | $15.7M | — | $1.7M | $16.2M | $-11.5M | — | $-7.3M | $44.2M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-5.3M | — | — | — | $34.4M | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $0 | — | — | — | — | — | — | — |
| Net Change in Cash | $10.4M | — | — | — | $22.8M | — | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |